Biography

Tim Matthews' practice focuses on public takeovers, mergers, acquisitions and sales, company reorganizations and LLP conversions. He acts for UK-listed, international and private companies particularly in the technology and life science sectors. His practice areas also cover UK corporate governance, business ethics and anti-corruption/bribery.

Prior to joining Brown Rudnick, Tim was a partner in the London office of Wilmer Cutler Pickering Hale and Dorr LLP. Here he was involved in all aspects of corporate law, advice and major commercial contracts. He also has an active pro bono practice.

Awards

Representation

Science Group plc on its acquisition of Technology Sciences Group, Inc for $17million.

Midatech Pharma PLC on its takeover, by way of merger, of DARA Biosciences Inc. and dual listing on AIM and NASDAQ, total value $30million.

Midatech Pharma PLC on its admission to AIM and simultaneous acquisition of Q Chip Ltd raising £32 million by way of placing. 

Thermo Fisher Scientific Inc on its acquisition of Phadia Diagnostics Group from Cinven for $3.5 billion.

Fairfax Financial Holdings Limited on its takeover offer for Advent Capital (Holdings) Plc which valued Advent at £67 million.

Cathedral Capital plc in relation to its £113 million takeover by Alchemy Partners and Management.

Microgen plc in relation to its takeover offers for MMT Computing plc and AFA Systems plc.

Education

University of Southampton – LLB, 1984

Bar Admissions

Solicitor, England and Wales

Languages

French
Spanish
Awards and Honors
Professional Memberships